PROTARA THERAPEUTIC INC

Protara Therapeutic Stock Falls 32% YoY, Outperforms Peers on Volatile Biotech Market

Protara Therapeutic stock dips 32% YoY; now trading at $2.49 amid biotech peers’ mixed moves – insight into volatility, valuation, and market sentiment.

PROTARA THERAPEUTIC INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Jake Connors

22/10/2026, 16:03

3 minutes to read

Protara Therapeutic (TARA) Surges 0.43% Amid Market Volatility, Holding Strong Specialty‑Disease Edge

Explore Protara Therapeutic’s recent market dynamics: TARA’s 0.43% rise, $2.56 price, 59M shares, and niche biotech upside amid macro volatility.

PROTARA THERAPEUTIC INC
United States
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

Samantha Roth

21/10/2026, 08:43

3 minutes to read